LN Future Invest AB, formerly Ellen AB, is a Sweden-based biotechnology company that produces probiotic sanitary protection products for women. The Companyâ€™s main product, Ellen tampon, contains patented natural lacto acid bacteria, Lacto Naturel (LN), and is used for maintaining the vaginal health. The Ellen tampon is made of natural fibers treated with the substance LN, which consists of human lactic acid bacteria, a natural part of healthy women's defense against infections. Ellen AB distributes its products in 37 countries, including Scandinavian countries, France, Germany, Czech Republic, Spain, Portugal, Poland and Belgium, among others.

Employees

Sector

Personal Products

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq Stockholm 17:00:00 23/02/2026 GMT			5-day change	1st Jan Change
0.9250 ^SEK	+6.94%		-.--%	+10.78%

02-25	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-15	LN Future Invest AB announces Annual dividend, payable on March 25, 2026	CI

Market Cap	10.25M 1.06M 911K 863K 782K 1.47M 101M 1.47M 3.94M 51.4M 3.97M 3.88M 162M	P/E 2024	-8.92x	P/E 2025	1.23x
Enterprise Value	-2.44M -252K -217K -205K -186K -349K -24.04M -351K -938K -12.23M -945K -924K -38.64M	EV / Sales 2024	0.37x	EV / Sales 2025	-0.24x
Free-Float	39.6%	Yield 2024 *	-	Yield 2025	75.4%

02-25	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-15	LN Future Invest AB announces Annual dividend, payable on March 25, 2026	CI
01-26	LN Future Invest to Be Delisted from First North, Last Trading Day Set for February 23	FW
01-26	Nasdaq Stockholm to delist LN Future Invest shares on Feb 23	RE
04/09/25	Ln Future Invest begins work on reverse acquisition opportunities	RE
29/08/25	Ln Future Invest H1 net sales at SEK 11.3 mln	RE
29/08/25	LN Future Invest AB Reports Earnings Results for the Half Year Ended June 30, 2025	CI
20/08/25	Ellen Completes Business Transfer to Addeira Pharmaceuticals	FW
10/07/25	Ellen enters into conditional agreement to sell business	RE
08/07/25	Addeira Pharmaceuticals Ab agreed to acquire Business of Ellen AB from Ellen AB (OM:ELN) for SEK 13.3 million.	CI
27/05/25	Ellen Q1 EBITDA Falls To SEK 102,000	RE
28/02/25	Ellen H2 EBIT Loss SEK 1 Mln	RE
28/02/25	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2024	CI

1 day	+6.94%
Current year	+10.78%

Ellen AB Share Price

Stocks

LNFI

SE0014730347

Personal Products

Valuation : Ellen AB

Chart: Ellen AB

Latest news : Ellen AB

Press Releases : Ellen AB

Quotes and Performance

Price Extremes

Managers and Directors : Ellen AB

Sanitary Products

Financials

Company Profile

Current year	0.75	0.92
1 year	0.58	1.28
3 years	0.49	2
5 years	0.49	7.58
10 years	0.49	79

Manager	Title	Age	Since
Sofia Fredrikson CEO	Chief Executive Officer	43	-
Sven Olof Mattsson IRC	Investor Relations Contact	65	30/04/2021
Lena De Wall ADM	Chief Administrative Officer	-	-

Director	Title	Age	Since
Jan Fredrik Mikael Lövgren BRD	Director/Board Member	65	08/07/2004
Sven Olof Mattsson CHM	Chairman	65	31/12/2024
Sofia Fredrikson BRD	Director/Board Member	43	17/09/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELLEN AB	+6.94%	-.--%	-22.92%	-9.31%	1.1M
KIMBERLY-CLARK CORPORATION	-0.34%	-6.49%	-24.19%	-23.35%	32.64B
UNICHARM CORPORATION	+0.67%	-1.80%	-2.51%	-49.65%	10.66B
HENGAN INTERNATIONAL GROUP COMPANY LIMITED	-2.91%	-2.54%	-17.86%	-26.60%	3.05B
GILLETTE INDIA LIMITED	-0.99%	-0.05%	-27.40%	+21.38%	2.49B
SOFTCARE LIMITED	+0.27%	-7.96%	-	-	2.32B
C&S PAPER CO.,LTD	-1.81%	-0.70%	-17.72%	-30.65%	1.33B
OIL-DRI CORPORATION OF AMERICA	+0.39%	-1.55%	+30.57%	+182.16%	1.25B
CHONGQING BAIYA SANITARY PRODUCTS CO., LTD.	+6.43%	+24.15%	-38.22%	+25.60%	1.17B
HANGZHOU HAOYUE PERSONAL CARE CO., LTD	-2.92%	-3.97%	-31.02%	-20.68%	764M
Average	+0.57%	-0.71%	-16.81%	+7.66%	5.57B
Weighted average by Cap.	-0.20%	-5.73%	-18.60%	-20.95%

	2024	2025
Net sales	23.48M 2.42M 2.09M 1.98M 1.79M 3.36M 231M 3.38M 9.03M 118M 9.1M 8.9M 372M	14.15M 1.46M 1.26M 1.19M 1.08M 2.03M 139M 2.04M 5.44M 70.96M 5.48M 5.36M 224M
Net income	-1.24M -128K -110K -105K -94.79K -178K -12.25M -179K -478K -6.23M -481K -471K -19.69M	7.51M 775K 667K 632K 573K 1.07M 74.01M 1.08M 2.89M 37.65M 2.91M 2.85M 119M
Net Debt	-2.43M -250K -216K -204K -185K -347K -23.92M -349K -933K -12.17M -940K -920K -38.46M	-12.69M -1.31M -1.13M -1.07M -968K -1.82M -125M -1.83M -4.88M -63.63M -4.92M -4.81M -201M